HIV-Associated Tuberculosis
Kogieleum Naidoo1, Kasavan Naidoo, Nesri Padayatchi
1CAPRISA Treatment Research Program, Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, 4013 Durban, South Africa.
Clinical & Developmental Immunology
|September 28, 2010
Summary
Managing coinfections of HIV and Tuberculosis (TB) in high-burden countries presents challenges in diagnosis, treatment, and prevention. Integrating services offers opportunities to improve patient outcomes and public health.
Area of Science:
- Public Health
- Infectious Diseases
- Epidemiology
Background:
- The dual epidemics of Human Immunodeficiency Virus (HIV) and Tuberculosis (TB) significantly impact high-burden countries.
- Coinfection presents complex clinical challenges for patient management and disease control.
Purpose of the Study:
- To outline key challenges and opportunities in managing patients coinfected with HIV and TB.
- To highlight the importance of integrated services for improving health outcomes.
Main Methods:
- Review of clinical and public health issues related to HIV-TB coinfection.
- Analysis of treatment strategies, including antiretroviral therapy (ART) and TB treatment initiation.
- Consideration of infection control, immune reconstitution, and sexual reproductive health.
Main Results:
- Key issues include TB diagnosis, ART drug selection, timing of ART initiation relative to TB treatment, immune reconstitution management, and recurrent TB.
- Minimizing airborne transmission and implementing infection control are critical.
- Sexual reproductive health and high TB mortality during pregnancy in women require specific attention.
Conclusions:
- Addressing HIV-TB coinfection requires integrated service delivery and resource allocation.
- Scale-up of ART access presents an opportunity to strengthen both HIV and TB services.
- Improved management can positively impact Millennium Development Goal 6 targets.
Related Concept Videos
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:26Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
01:23Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
01:28Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
01:31Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...